Ultimovacs ASA (ULTI) — Financial Flexibility Index
Ultimovacs ASA (ULTI) has a Financial Flexibility Index of -0.74x as of December 2024. Free cash flow of Nkr-24.70 Million (operating CF Nkr-24.70 Million minus capex Nkr0.00) represents -1% of total liabilities (Nkr33.19 Million). Also explore Ultimovacs ASA annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ultimovacs ASA Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Ultimovacs ASA across 9 annual periods. Check ULTI strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Ultimovacs ASA (2016–2024)
Year-by-year free cash flow to debt coverage for Ultimovacs ASA. For the full company profile including market capitalisation, see ULTI company net worth.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.92x | Nkr-163.39 Million | Nkr-163.40 Million | Nkr33.19 Million | ▼ -80.6% |
| 2023 | -2.73x | Nkr-189.80 Million | Nkr-189.83 Million | Nkr69.65 Million | ▲ +1.9% |
| 2022 | -2.78x | Nkr-167.50 Million | Nkr-167.69 Million | Nkr60.32 Million | ▼ -37.8% |
| 2021 | -2.02x | Nkr-125.74 Million | Nkr-125.83 Million | Nkr62.38 Million | ▲ +22.8% |
| 2020 | -2.61x | Nkr-107.94 Million | Nkr-108.22 Million | Nkr41.34 Million | ▼ -38.9% |
| 2019 | -1.88x | Nkr-62.82 Million | Nkr-62.99 Million | Nkr33.41 Million | ▼ -12.9% |
| 2018 | -1.66x | Nkr-49.88 Million | Nkr-50.39 Million | Nkr29.96 Million | ▲ +24.4% |
| 2017 | -2.20x | Nkr-27.20 Million | Nkr-27.23 Million | Nkr12.35 Million | ▲ +50.5% |
| 2016 | -4.45x | Nkr-30.31 Million | Nkr-31.10 Million | Nkr6.81 Million | — |